Sleep apnoea services are overwhelmed by the large number of patients requiring treatment and follow-up. New solutions are needed to manage the growing caseload. Centralized call centers using telemonitoring of CPAP machines and home sleep studies with wireless data transmission could help by allowing remote patient support and diagnosis, reducing the burden on clinic resources. These approaches aim to improve access to care for the many people affected by undiagnosed sleep apnoea.
Self-management in the community and on the Internet - Presentation 22nd Marc...NHS Improving Quality
LTC Lunch & Learn webinar:- 22nd March 2016
Presenter:- Pete Moore, Educator, Author & Pain Toolkit Trainer
As pain is the most daily health problem reported to a GP-
Developing a national pain strategy- reviews from around the world
This is our Business Plan for the next year; 2017-18.
In health, as in other sectors, innovation and adoption at scale is increasingly driven by interdisciplinary research, synergies between industries, and a step-change in end-user (citizen, consumer, patient) engagement in the process. Seeing the wood from the trees, making connections, spotting opportunities, and understanding how to get traction requires a breadth of perspective and strong roots into, and across, that landscape.
Academic Health Science Networks (AHSNs) connect horizontally across research, industries, commissioners, providers and users; and network vertically between policy formulation, system design, operational coal-face and end-user experience. That role takes us across all parts of the NHS, into industry, local government and other public agencies, into universities, charities, start-ups, and into funders. And up and down the system; from the role of the GP receptionist in improvement and innovation; to dialogue with policy makers and regulators about refining system design to support adoption and spread of innovation.
Networks which are open to, and embrace, the diverse perspectives of these stakeholders will, in turn, help the systems and members which they support be open to the adoption and spread of innovation.
That is what we, Wessex AHSN, aspire to. We hope you find this spirit reflected in our business plan.
Transforming End of Life Care in Acute Hospitals PM Workshop 3: Vital Signs ‘...NHS Improving Quality
Transforming End of Life Care in Acute Hospitals PM Workshop 3: Vital Signs ‘Making Measurement Better’ How well things are going and how to make it better’ presented by Sean Manning, NHS England
Self-management in the community and on the Internet - Presentation 22nd Marc...NHS Improving Quality
LTC Lunch & Learn webinar:- 22nd March 2016
Presenter:- Pete Moore, Educator, Author & Pain Toolkit Trainer
As pain is the most daily health problem reported to a GP-
Developing a national pain strategy- reviews from around the world
This is our Business Plan for the next year; 2017-18.
In health, as in other sectors, innovation and adoption at scale is increasingly driven by interdisciplinary research, synergies between industries, and a step-change in end-user (citizen, consumer, patient) engagement in the process. Seeing the wood from the trees, making connections, spotting opportunities, and understanding how to get traction requires a breadth of perspective and strong roots into, and across, that landscape.
Academic Health Science Networks (AHSNs) connect horizontally across research, industries, commissioners, providers and users; and network vertically between policy formulation, system design, operational coal-face and end-user experience. That role takes us across all parts of the NHS, into industry, local government and other public agencies, into universities, charities, start-ups, and into funders. And up and down the system; from the role of the GP receptionist in improvement and innovation; to dialogue with policy makers and regulators about refining system design to support adoption and spread of innovation.
Networks which are open to, and embrace, the diverse perspectives of these stakeholders will, in turn, help the systems and members which they support be open to the adoption and spread of innovation.
That is what we, Wessex AHSN, aspire to. We hope you find this spirit reflected in our business plan.
Transforming End of Life Care in Acute Hospitals PM Workshop 3: Vital Signs ‘...NHS Improving Quality
Transforming End of Life Care in Acute Hospitals PM Workshop 3: Vital Signs ‘Making Measurement Better’ How well things are going and how to make it better’ presented by Sean Manning, NHS England
The AHSN and Centre for Implementation Science is working as the independent evaluator for the Happy, Healthy, at Home Vanguard programme in North East Hampshire and Farnham.
This was the second symposium of the independent evaluation and focused on the Farnham Locality. The event included presentations from the Farnham Integrated Care Team and the Farnham Referral Management Service, as well as a series of ‘Evaluation Stations’ where delegates spent time with teams from Farnham, North East Hampshire and Farnham CCG and NHS England.
The event was attended by a wide-range of people who are interested in seeing how the vanguard programme is making changes to the local health system in North East Hampshire and Farnham and who are interested in evaluation approaches. These are the collected slides from the day.
An overview of the work carried out by NHS England and NHS Improving Quality's Long Term Conditions Sustainable Improvement Team. It puts the case for why person-centred care has to be at the heart of healthcare.
Improvement Story session at the 2013 Saskatchewan Health Care Quality Summit. For more information about the summit, visit www.qualitysummit.ca. Follow @QualitySummit on Twitter.
Better Care for clients and families experiencing or at risk for stroke or transient ischemic attacks (TIA's) using telehealth and multidisciplinary and inter-regional resources was realized in Sunrise Health Region over the course of a two year pilot.
Better Care
Jacquie Holzmann, Sunrise Health Region, Shannon Schmidt, Sunrise Health Region
Slides from a lunch and learn webinar hosted by NHS England's Long Term Conditions Team, on the topic of health coaching by lay professionals.
The speakers and Anya de Longh and Jim Phillips.
Transforming End of Life Care in Acute Hospitals AM Workshop 2: AMBER Care Bu...NHS Improving Quality
Transforming End of Life Care in Acute Hospitals AM Workshop 2: AMBER Care Bundle by Dr Irene Carey, Susanna Shouls, Guy’s and St Thomas’ NHS Foundation Trust
3.4 - Workforce and developing multi-disciplinary teams in primary careNHS England
The importance of the workforce needs in Beds, Luton and Milton Keynes, what does it mean to the people on the ground and how are they going to be affected. How will it improve their working lives?
Better outcomes, better value: integrating physical and mental health into clinical practice and commissioning
Tuesday 24 June 2014: 15 Hatfields, Chadwick Court, London
The AHSN and Centre for Implementation Science is working as the independent evaluator for the Happy, Healthy, at Home Vanguard programme in North East Hampshire and Farnham.
This was the second symposium of the independent evaluation and focused on the Farnham Locality. The event included presentations from the Farnham Integrated Care Team and the Farnham Referral Management Service, as well as a series of ‘Evaluation Stations’ where delegates spent time with teams from Farnham, North East Hampshire and Farnham CCG and NHS England.
The event was attended by a wide-range of people who are interested in seeing how the vanguard programme is making changes to the local health system in North East Hampshire and Farnham and who are interested in evaluation approaches. These are the collected slides from the day.
An overview of the work carried out by NHS England and NHS Improving Quality's Long Term Conditions Sustainable Improvement Team. It puts the case for why person-centred care has to be at the heart of healthcare.
Improvement Story session at the 2013 Saskatchewan Health Care Quality Summit. For more information about the summit, visit www.qualitysummit.ca. Follow @QualitySummit on Twitter.
Better Care for clients and families experiencing or at risk for stroke or transient ischemic attacks (TIA's) using telehealth and multidisciplinary and inter-regional resources was realized in Sunrise Health Region over the course of a two year pilot.
Better Care
Jacquie Holzmann, Sunrise Health Region, Shannon Schmidt, Sunrise Health Region
Slides from a lunch and learn webinar hosted by NHS England's Long Term Conditions Team, on the topic of health coaching by lay professionals.
The speakers and Anya de Longh and Jim Phillips.
Transforming End of Life Care in Acute Hospitals AM Workshop 2: AMBER Care Bu...NHS Improving Quality
Transforming End of Life Care in Acute Hospitals AM Workshop 2: AMBER Care Bundle by Dr Irene Carey, Susanna Shouls, Guy’s and St Thomas’ NHS Foundation Trust
3.4 - Workforce and developing multi-disciplinary teams in primary careNHS England
The importance of the workforce needs in Beds, Luton and Milton Keynes, what does it mean to the people on the ground and how are they going to be affected. How will it improve their working lives?
Better outcomes, better value: integrating physical and mental health into clinical practice and commissioning
Tuesday 24 June 2014: 15 Hatfields, Chadwick Court, London
What is Inspire? by Dr. Ruchir P. PatelRuchirPPatel
Dr. Ruchir P. Patel, a sleep medicine specialist at The Insomnia and Sleep Institute of Arizona in Phoenix, AZ, and a member of the Inspire Excellence Program discusses what Inspire therapy is and how it works to treat obstructive sleep apnea (OSA).
Final newer modes and facts niv chandanChandan Sheet
THIS IS THE BASIC POINTS REGARDING NIV, THIS IS COMPILED AND ARRANGED FROM DIFFERENT BOOKS, JOURNALS AND PPTs.
The author is grateful to the teachers and authors of pulmonology and critical care.
Partners in health's Implemention of OpenMRS in Neno, MalawiLimbani Thengo
Presentation by Partners in Health (Malawi) given at the 2017 International OpenMRS Implementers' Conference at Bingu International Conference Center in Lilongwe, Malawi.
By Marc Newell, MD. A discussion about the rapidly evolving TeleHealth program at Minneapolis Heart Institute that promises to increase access to and timeliness of specialty care in communities across the region. “This is an innovative strategy that allows more patients to be seen closer to home, and have more access to subspecialty care. We need to transform how and where we deliver care so we can focus on prevention and chronic disease management.”
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
The NHS Five Year Plan-John stradling presentation
1. Sleep Apnoea – new approaches to managing
the burgeoning national caseload
John Stradling
Emeritus Professor of respiratory Medicine
Oxford University
Conflict of interests statement – I do some consulting work for ResMed UK
2. Outline of presentation
• What is sleep apnoea and why is it an important disease?
• What is the current patient pathway?
• Why is there a crisis in sleep apnoea services?
• What needs to change?
• What new solutions are out there?
• Other areas in sleep apnoea management that could benefit
from new technology
3. What is sleep apnoea and why is it an important disease?
• Sleep apnoea - breathing repeatedly stops during sleep producing major adverse
physiological changes, but SLEEPINESS is the dominant symptom
• Patients with this condition stop breathing often hundreds of time a night, of
which they are not aware, and as a consequence suffer from unexplained daytime
sleepiness
• Of major concern is that this sleepiness leads to a myriad of deleterious
consequences, of which falling asleep driving is one of the most concerning
• There is an extraordinarily effective treatment called continuous positive airway
pressure (CPAP) which patients use most nights, for most of the night
• This treatment abolishes the symptoms and has been strongly endorsed by NICE
(TA139)
5. What is sleep apnoea and why is it an important disease?
• Sleep apnoea - breathing repeatedly stops during sleep producing major adverse
physiological changes, but SLEEPINESS is the dominant symptom
• Patients with this condition stop breathing often hundreds of time a night, of
which they are not aware, and as a consequence suffer from unexplained daytime
sleepiness
• Of major concern is that this sleepiness leads to a myriad of deleterious
consequences, of which falling asleep driving is one of the most concerning
• There is an extraordinarily effective treatment called continuous positive airway
pressure (CPAP) which patients use most nights, for most of the night
• This treatment abolishes the symptoms and has been strongly endorsed by NICE
(TA139)
7. What is sleep apnoea and why is it an important disease?
• Sleep apnoea - breathing repeatedly stops during sleep producing major adverse physiological
changes, but SLEEPINESS is the dominant symptom
• Patients with this condition stop breathing often hundreds of time a night, of which they are
not aware, and as a consequence suffer from unexplained daytime sleepiness
• Of major concern is that this sleepiness leads to a myriad of deleterious consequences, of
which falling asleep driving is one of the most concerning
• There is an extraordinarily effective treatment called continuous positive airway pressure
(CPAP) which patients use most nights, for most of the night
• This treatment abolishes the symptoms and
has been strongly endorsed by NICE
http://www.nice.org.uk/guidance/ta139
• NICE has recommended fast tracking vocational drivers following an initiative by the OSA
partnership, to try and ensure such patients are diagnosed, treated and back on the road
within 4 weeks. http://cks.nice.org.uk/obstructive-sleep-apnoea-syndrome#!scenario
8. Current patient pathway
GP suspects sleep apnoea
Referral to hospital sleep unit
Sleep study and outpatient assessment
Put on CPAP if indicated
Immediate follow up
+ extra appointments if needed
Annual follow up
9. Why is there a crisis in sleep apnoea services?
• Sleep apnoea is common. Sleep apnoea, benefitting from treatment with CPAP,
affects about 2% of the adult population
• This equates to about a million people, and the best estimate of patients currently
on CPAP is 230,000
• This means that there are still 770,000 patients undiagnosed
• It is recommended that all patients on CPAP are followed, at least annually to ensure
treatment remains efficacious and all problems are solved to ensure good
compliance, (NICE, IMPRESS (BTS), ARTP, BLF)
• Routine follow-up alone of current patients would thus lead to 230,000 outpatient
appointments a year, which at a cost of £120 per appointment would cost the
country £28 million!
• We are victims of our own success and services are now overwhelmed
11. What needs to change?
When staff running sleep units are asked -
“what is the biggest load that impacts on your service?”
It is the routine follow-ups, interim patient phone calls, and
emails etc. that crush the service
These are mainly relatively simple problem solving, providing
information, replacement masks, broken kit etc
Without this service load of relatively ‘simple’ tasks they could
concentrate on the more skilled activities within the sleep unit.
12. What new solutions are out there?
Centralised call centres benefitting from:
• Economies of scale
• Recruiting issues, larger staff pool buffers holidays/sick leave etc
• High standard approach to all patients and their problems across the country
• Staff training becomes a continuous activity within the call centre
• Can help both large and small services, delivering the same service to patients
• Full range of replacement kit, rapid response times to send out
• Extended working hours
• Comprehensive database allowing rapid identification of who is calling and their
details
Country-wide service provided by a company in cooperation with the sleep unit
Several such services already in operation, but currently low take-up by NHS
– perverse incentives limit this avenue
13. What new solutions are out there?
Telemonitoring:-
When a patient rings up with a problem, instantly being able to interrogate
their CPAP machine would allow most problems to be solved there and then
CPAP machines monitor:
• Usage – i.e. how much is the patient using the treatment
• Mask leak – a common problem that can be addressed
• Residual sleep apnoea – is the system working
• Any machine faults – might explain the patient’s problem
This used to require patient attendance at the clinic to collect this information
Then there were data cards that could be sent back in the post
Now this can be done remotely via wireless/mobile phone technology
Provides instant information to the person answering the call
The settings on the machine (e.g. pressure) can be adjusted remotely as well
14. Immediate follow up of patients recently starting CPAP
The first few days following the introduction of CPAP are critical
• Patterns of usage are set within the first week
• Important to identify early ‘failing’ patients
Good
Not very good
Printouts from ResMed AirViewTM, part of ResMed Air Solutions
15. Display of patients recently starting CPAP
Printouts from ResMed AirViewTM, part of ResMed Air Solutions
Current ResMed CPAP machine with
built in Wireless communications
16. Example of a Unit adopting
telemonitoring
• Sleep Clinic, 1 consultant and 4 clinicians
• 500 new CPAP set-ups/year, 2,000 on CPAP already
• Overload, failing to meet 18 week treatment target
• “There was no scope for extra staff to cope with
rapidly increasing demand” Claire Goulden
Introduced AirView TM, part of ResMed Air Solutions in October 2014
• They were able to replace current routine follow-ups with targeted phone
calls, or appointments, only for those who needed this input
• They were able to quickly identify new patients experiencing problems and
spend more time on them
• Far fewer outpatient appointments and thus far less patient inconvenience
• Time saved allowed time to be spent with more complex patients, such as
those needing NIV
They had full management support for what was clearly a better system
17. Other areas in sleep apnoea management that could
benefit from new technology
Given that OSA is:-
• Very common
• Under-diagnosed
• For which there is a highly effective treatment
• Been around a long while (cf hypertension, diabetes)
It should and will become much more a primary care issue
Simple home screening equipment - now fully accepted for sleep apnoea
diagnosis
Needs simple, reliable devices
Results need to be easily available to a variety of clinicians, GPs, consultants,
sleep nurses, sleep technicians involved in the patients’ care
18. Home sleep apnoea diagnosis – e.g. ApneaLink™Air
• Can be uploaded to the cloud so that other clinicians in any location can see
the data instantly
• This facility would be particularly appropriate when the GP does the sleep
study and the consultant needs to see the sleep study when assessing the
patient later
19. Abbreviated summary page to
help with referral decisions
Full data display for the
sleep centre clinician
ResMed ApneaLink™Air - results
20. Conclusions
Sleep services are in crisis, they need new ways of working to solve
the ever increasing numbers of patients starting CPAP and requiring
follow-up
The best solution requires large centralised call centres and CPAP
machines equipped with wireless technology
Sleep apnoea is underdiagnosed and waiting lists for diagnostic
services are growing
Home sleep studies by GPs, with wireless technology for
transmitting the results to the sleep centre, provides a solution